Back to company

Cyclomedica Danmark ApS: Financial statements 2022

CVR: 16582891

Cyclomedica Danmark ApS (CVR 16582891) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 622,242 and a net result of DKK -394,454 compared with DKK -379,161 the year before. That is a decrease of 7.2% compared with the year before. Equity amounted to DKK 1,027,677. The solvency ratio was 55.9%. The company had 3 employees in the financial year.

Gross Profit
622,242 kr.
Profit/Loss
-394,454 kr.
Equity
1,027,677 kr.
Total Assets
1,839,660 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-622 t.-394 t.1 mio.3
2021-671 t.-379 t.1.4 mio.3
2020-1.3 mio.115 t.1.9 mio.3
2019-1.7 mio.425 t.2.2 mio.3
2018-1.7 mio.373 t.2.1 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2022

Cyclomedica Danmark ApS: The 2021 annual report is outMar 10, 2022

Cyclomedica Danmark ApS has published its annual report for 2021. Gross profit came to DKK 670,823, and the net result was DKK -379,161.

About Cyclomedica Danmark ApS

Cyclomedica Danmark ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Fritz Rode Jakobsen. The company is owned by Cyclomedia Europe Limited. The company has 3 employees. In 2025, the company reported a gross profit of DKK 559,660 and a net result of DKK 135,961 compared with DKK -5,806 the year before. Equity amounted to DKK 478,864.